Rrad-KO Mouse
一般名
Rrad-KO
製品ID
S-KO-16694
背景情報
C57BL/6JCya
系統ID
KOCMP-56437-Rrad-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Rrad-KO Mouse（カタログ番号S-KO-16694）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Rrad-KO
系統ID
KOCMP-56437-Rrad-B6J-VB
遺伝子名
製品ID
S-KO-16694
遺伝子別名
Rad, REM3
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000034351
NCBIトランスクリプトID
NM_019662
ターゲット領域
Exon 3~5
有効領域の大きさ
~2.5 kb
遺伝子研究の概要
RRAD, short for Ras-related associated with diabetes, is a member of the Ras-related GTPase superfamily. Primarily a cytosolic protein that acts in the plasma membrane, it is highly expressed in type 2 diabetes patients and serves as a biomarker for congestive heart failure. RRAD is involved in various cellular activities including cell division, motility, apoptosis, and energy metabolism through modulating tumor-related gene expression and interacting with multiple downstream effectors [1].
In cancer research, RRAD shows dual roles. In gastric and colorectal cancer, its inhibition reduces tumor cell proliferation, invasion, angiogenesis, and EMT marker expression, suggesting it could be a therapeutic target [2]. In papillary thyroid cancer, it is part of the NEAT1_2/RRAD/EHF positive feedback loop facilitating glycolysis [3]. In hepatocellular carcinoma, RRAD suppresses the Warburg effect by downregulating ACTG1, inhibiting cell proliferation and promoting apoptosis [4]. In lung cancer, it inhibits the Warburg effect via negative regulation of the NF-κB signaling [5]. In contrast, in glioblastoma, RRAD promotes EGFR-mediated STAT3 activation and temozolomide resistance [6]. In oral squamous cell carcinoma, downregulation of RRAD in the tumor margin enhances energy metabolism and tumor progression [7]. Also, RRAD is identified as a marker and negative regulator of cellular senescence, up-regulated in senescent cells and countering cellular senescence by reducing reactive oxygen species levels [8].
In summary, RRAD has diverse and context-dependent functions. In cancer, it can act as either an oncogene or a tumor suppressor. Its role in energy metabolism, cell proliferation, and apoptosis is crucial in understanding disease mechanisms. Studies on RRAD, especially through functional loss-of-function experiments, contribute to uncovering its complex roles in different diseases, providing potential therapeutic targets for cancers and insights into cellular senescence.
References:
1. Sun, Zhangyue, Li, Yongkang, Tan, Xiaolu, Xu, Liyan, Long, Lin. 2023. Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer. In Biomolecules, 13, . doi:10.3390/biom13030477. https://pubmed.ncbi.nlm.nih.gov/36979412/
2. Kim, Hee Kyung, Lee, Inkyoung, Kim, Seung Tae, Park, Joon Oh, Kang, Won Ki. 2019. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis. In Scientific reports, 9, 19439. doi:10.1038/s41598-019-55767-7. https://pubmed.ncbi.nlm.nih.gov/31857616/
3. Sun, Wei, Wang, Zhiyuan, Qin, Yuan, He, Liang, Zhang, Hao. . NEAT1_2/RRAD/EHF Positive Feedback Loop Facilitates Aerobic Glycolysis in Papillary Thyroid Cancer Cells. In Endocrinology, 164, . doi:10.1210/endocr/bqad085. https://pubmed.ncbi.nlm.nih.gov/37279586/
4. Yan, Yingcai, Xu, Hao, Zhang, Linshi, Ge, Wenhao, Wang, Weilin. 2019. RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma. In OncoTargets and therapy, 12, 1691-1703. doi:10.2147/OTT.S197844. https://pubmed.ncbi.nlm.nih.gov/30881024/
5. Liu, Juan, Zhang, Cen, Wu, Rui, Yang, Bo, Feng, Zhaohui. . RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling. In Oncotarget, 6, 14982-92. doi:. https://pubmed.ncbi.nlm.nih.gov/25893381/
6. Yeom, Seon-Yong, Nam, Do-Hyun, Park, Chaehwa. 2014. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. In Molecular cancer therapeutics, 13, 3049-61. doi:10.1158/1535-7163.MCT-14-0244. https://pubmed.ncbi.nlm.nih.gov/25313011/
7. Cheng, Aoming, Xu, Qiaoshi, Li, Bo, Han, Zhengxue, Feng, Zhien. 2024. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma. In Cell death & disease, 15, 376. doi:10.1038/s41419-024-06759-7. https://pubmed.ncbi.nlm.nih.gov/38811531/
8. Wei, Zhao, Guo, Haiyang, Qin, Junchao, Gong, Yaoqin, Shao, Changshun. 2018. Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence. In Free radical biology & medicine, 130, 267-277. doi:10.1016/j.freeradbiomed.2018.10.457. https://pubmed.ncbi.nlm.nih.gov/30391675/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。